TY  - JOUR

T1  - An update on the safety and tolerability of pimecrolimus cream 1%: Evidence from clinical trials and post-marketing surveillance

JO  - DERMATOLOGY

PY  - 2007/01/01

AU  - Langley RGB

AU  - Luger TA

AU  - Cork MJ

AU  - Schneider D

AU  - Paul C

ED  - 

DO  - DOI: 10.1159/000102118

VL  - 215

SP  - 27

EP  - 44

Y2  - 2024/12/22

ER  -